BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20087440)

  • 21. ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.
    Zhang Q; Xiao M; Gu S; Xu Y; Liu T; Li H; Yu Y; Qin L; Zhu Y; Chen F; Wang Y; Ding C; Wu H; Ji H; Chen Z; Zu Y; Malkoski S; Li Y; Liang T; Ji J; Qin J; Xu P; Zhao B; Shen L; Lin X; Feng XH
    Nat Cell Biol; 2019 Feb; 21(2):179-189. PubMed ID: 30664791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
    Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
    Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells.
    Ali NA; McKay MJ; Molloy MP
    Mol Biosyst; 2010 Nov; 6(11):2332-8. PubMed ID: 20862427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
    Zhang Y; Musci T; Derynck R
    Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wip1 regulates Smad4 phosphorylation and inhibits TGF-β signaling.
    Park DS; Yoon GH; Kim EY; Lee T; Kim K; Lee PC; Chang EJ; Choi SC
    EMBO Rep; 2020 May; 21(5):e48693. PubMed ID: 32103600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
    Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
    Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of transforming growth factor-beta signaling in cancer.
    de Caestecker MP; Piek E; Roberts AB
    J Natl Cancer Inst; 2000 Sep; 92(17):1388-402. PubMed ID: 10974075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-to-cell spread of vaccinia virus is promoted by TGF-β-independent Smad4 signalling.
    Gowripalan A; Abbott CR; McKenzie C; Chan WS; Karupiah G; Levy L; Newsome TP
    Cell Microbiol; 2020 Aug; 22(8):e13206. PubMed ID: 32237038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
    Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
    Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.
    Hoshino Y; Nishida J; Katsuno Y; Koinuma D; Aoki T; Kokudo N; Miyazono K; Ehata S
    Am J Pathol; 2015 May; 185(5):1457-70. PubMed ID: 25769430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β/SMAD4 signaling pathway activates the HAS2-HA system to regulate granulosa cell state.
    Li X; Du X; Yao W; Pan Z; Li Q
    J Cell Physiol; 2020 Mar; 235(3):2260-2272. PubMed ID: 31489963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
    Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
    Wurthner JU; Frank DB; Felici A; Green HM; Cao Z; Schneider MD; McNally JG; Lechleider RJ; Roberts AB
    J Biol Chem; 2001 Jun; 276(22):19495-502. PubMed ID: 11278302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
    Chen F; Zhuang M; Peng J; Wang X; Huang T; Li S; Lin M; Lin H; Xu Y; Li J; Chen Z; Huang Y
    Mol Med Rep; 2014 Oct; 10(4):1999-2003. PubMed ID: 25109410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.
    Azmi PB; Seth AK
    Anticancer Res; 2009 Jun; 29(6):2253-63. PubMed ID: 19528490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-beta signaling.
    Chen YG; Wang Z; Ma J; Zhang L; Lu Z
    J Biol Chem; 2007 Mar; 282(13):9688-9695. PubMed ID: 17272273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Smad family and its role in pancreatic cancer.
    Singh P; Wig JD; Srinivasan R
    Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
    Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
    Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.